Correction: Combined inhibition of PI3K and Src kinases demonstrates synergistic therapeutic efficacy in clear-cell renal carcinoma

Oncotarget. 2019 Mar 15;10(22):2236. doi: 10.18632/oncotarget.26807.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.25700.].

Publication types

  • Published Erratum